Biggest News Aggregation in the World
📰 Nasdaq Coll News

Page 2 - Nasdaq Coll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $435,915.48 in Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CEO Joseph Ciaffoni sold 14,516 shares of the company’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $30.03, for a total transaction of $435,915.48. Following the completion of the transaction, the chief executive officer now directly owns 275,000 […]
Los Angeles United States Joseph Ciaffoni Collegium Pharmaceutical Company Profile Collegium Pharmaceutical Inc Principal Financial Group Inc

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Wednesday morning. Separately, Needham & Company LLC raised their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research report on Friday, August […]
Los Angeles United States Shirleyr Kuhlmann Principal Financial Group Inc Needham Company Commonwealth Of Pennsylvania Public School Empls Retrmt

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Strong-Buy by StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Needham & Company LLC increased their price objective on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research note on […]
United States Shirleyr Kuhlmann Securities Exchange Commission American Century Companies Inc Collegium Pharmaceutical Company Profile Financial Services Group Inc

Collegium Pharmaceutical (NASDAQ:COLL) Cut to Buy at StockNews.com

StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday morning. Separately, Needham & Company LLC increased their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the company a buy rating in a research report on Friday, […]
Los Angeles United States Shirleyr Kuhlmann Collegium Pharmaceutical Inc Brandywine Global Investment Management Securities Exchange Commission

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Down 7.3% in October

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) saw a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 6,010,000 shares, a drop of 7.3% from the October 15th total of 6,480,000 shares. Approximately 17.8% of the shares of the company are short sold. Based […]
Altshuler Shaham Ltd Collegium Pharmaceutical Inc Collegium Pharmaceutical Company Profile Wealthplan Investment Management Tower Group Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Short Interest in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Grows By 28.6%

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 7,640,000 shares, a growth of 28.6% from the July 31st total of 5,940,000 shares. Currently, 22.6% of the company’s shares are sold short. […]
United States Shirleyr Kuhlmann Joseph Ciaffoni Needham Company Wells Fargo Company Collegium Pharmaceutical Inc
Source: wkrb13.com

Collegium Pharmaceutical (NASDAQ:COLL) Price Target Raised to $36.00

Collegium Pharmaceutical (NASDAQ:COLL – Free Report) had its price objective lifted by Needham & Company LLC from $35.00 to $36.00 in a report published on Friday morning, MarketBeat reports. Needham & Company LLC currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts have also recently weighed in […]
United States Shirleyr Kuhlmann Joseph Ciaffoni Collegium Pharmaceutical Company Profile Needham Company Pricet Rowe Associates Inc

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Up 28.6% in August

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 7,640,000 shares, an increase of 28.6% from the July 31st total of 5,940,000 shares. Approximately 22.6% of the shares of the company are […]
United States Shirleyr Kuhlmann Joseph Ciaffoni Securities Exchange Commission Citigroup Inc Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by South Dakota Investment Council

South Dakota Investment Council trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 11.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 248,972 shares of the specialty pharmaceutical company’s stock after selling 32,600 shares […]
United States Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Citigroup Inc American Century Companies Inc
Source: wkrb13.com

Short Interest in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Drops By 9.6%

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 5,940,000 shares, a drop of 9.6% from the July 15th total of 6,570,000 shares. Currently, 17.6% of the company’s stock are short sold. […]
Shirleyr Kuhlmann Joseph Ciaffoni Piper Sandler Blackrock Inc Principal Financial Group Inc Collegium Pharmaceutical Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science